what is glp -1 GLP-1 & Does it Affect Weight & Cognition? GLP-1s: What They Are and

Clinical trials have shown this dose produces significant weight loss over 56 weeks, with many participants achieving 510 % of baseline body weight reduction

Frequently Asked Questions Orforglipron (LY3502970) is an investigational oral, non-peptide, small-molecule GLP-1 receptor agonist developed by Eli Lilly

Dual-agonist combinations are being developed for diabetes (see Tirzepatide from Eli Lilly or BI 456906 from Zealand Pharma ), but KP405 has been designed to penetrate the blood brain barrier for testing in neurodegenerative conditions

Pricing is structured as one transparent monthly fee covering consultation, medication, and shipping, with compounded semaglutide plans starting as low as $174 per month and compounded tirzepatide plans starting around $283 per month depending on the commitment length chosen